Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12702]

FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma

FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma

The ‘Time To Act’ data navigator – A new landmark tool in the fight against the impact of COVID-19 on cancer

The ‘Time To Act’ data navigator – A new landmark tool in the fight against the impact of COVID-19 on cancer

Practice-changing trial results for advanced melanoma skin cancer

Practice-changing trial results for advanced melanoma skin cancer

Fasting-mimicking diet is safe, may modulate metabolism and boost antitumour immunity in cancer patients

Fasting-mimicking diet is safe, may modulate metabolism and boost antitumour immunity in cancer patients

Scientists identify new types of a blood cancer and potential targeted treatments

Scientists identify new types of a blood cancer and potential targeted treatments

Giving immunotherapy before targeted therapy improves survival in advanced melanoma

Giving immunotherapy before targeted therapy improves survival in advanced melanoma

The prostate cancer cell that got away

The prostate cancer cell that got away

Researchers discover unique metabolic vulnerabilities of subsets of triple-negative breast cancer

Researchers discover unique metabolic vulnerabilities of subsets of triple-negative breast cancer

Using T cells to target malignant brain tumours

Using T cells to target malignant brain tumours

Results from a French study indicate that the COVID-19 vaccine is effective in patients with lung cancer

Results from a French study indicate that the COVID-19 vaccine is effective in patients with lung cancer

More from ecancer